Locations

United States · Menlo Park, CA, USA · San Francisco, CA, USA · North America

industry

Biotechnology · DeepTech · Health

Size

1001-5000 employees

Stage

Series C+

founded in

2016

Grail develops a pan-cancer screening test designed to detect cancers at an early stage. Its pan-cancer screening test measures circulating nucleic acids in blood using high-intensity sequencing, population-scale clinical trials, enabling doctors to develop blood tests for early-stage cancer detection. The company was founded in 2016 by Alex Aravanis and Jeff Huber in Menlo Park, California.

Something looks off?
Open jobs at Grail

On-site & Remote